Fabry's disease physical examination: Difference between revisions
Jump to navigation
Jump to search
Jose Loyola (talk | contribs) No edit summary |
No edit summary |
||
(8 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Fabry's disease}} | {{Fabry's disease}} | ||
{{CMG}} {{AE}} {{GhazalS}} | |||
{{CMG}} {{AE}} | |||
==Overview== | ==Overview== | ||
The presence of angiokeratomas on physical examination is highly suggestive of Fabry's disease. other physical examinations | The presence of [[angiokeratomas]] on [[physical examination]] is highly suggestive of [[Fabry's disease]]. other physical examinations can be varied due to organ involvement. | ||
==Physical Examination== | ==Physical Examination== | ||
Line 11: | Line 10: | ||
===Appearance=== | ===Appearance=== | ||
*Severe [[growth retardation]] | *Severe [[growth retardation]]<ref name="pmid25232851">{{cite journal| author=Laney DA, Peck DS, Atherton AM, Manwaring LP, Christensen KM, Shankar SP | display-authors=etal| title=Fabry disease in infancy and early childhood: a systematic literature review. | journal=Genet Med | year= 2015 | volume= 17 | issue= 5 | pages= 323-30 | pmid=25232851 | doi=10.1038/gim.2014.120 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25232851 }}</ref> | ||
*Extreme mental and motor retardation | *Extreme mental and motor retardation<ref name="pmid25319043">{{cite journal| author=Sigmundsdottir L, Tchan MC, Knopman AA, Menzies GC, Batchelor J, Sillence DO| title=Cognitive and psychological functioning in Fabry disease. | journal=Arch Clin Neuropsychol | year= 2014 | volume= 29 | issue= 7 | pages= 642-50 | pmid=25319043 | doi=10.1093/arclin/acu047 | pmc=4263929 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25319043 }}</ref> | ||
===Vital Signs=== | ===Vital Signs=== | ||
*[[Irregularly irregular pulse]] may be present from [[cardiac arrhythmia]]s | *[[Irregularly irregular pulse]] may be present from [[cardiac arrhythmia]]s<ref name="pmid21092187">{{cite journal| author=Germain DP| title=Fabry disease. | journal=Orphanet J Rare Dis | year= 2010 | volume= 5 | issue= | pages= 30 | pmid=21092187 | doi=10.1186/1750-1172-5-30 | pmc=3009617 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21092187 }}</ref> | ||
*[[Blood pressure]] may be raised | *[[Blood pressure]] may be raised<ref name="pmid210921872">{{cite journal| author=Germain DP| title=Fabry disease. | journal=Orphanet J Rare Dis | year= 2010 | volume= 5 | issue= | pages= 30 | pmid=21092187 | doi=10.1186/1750-1172-5-30 | pmc=3009617 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21092187 }}</ref> | ||
*[[Pyrexia of unknown origin]] | *[[Pyrexia of unknown origin]] | ||
Line 25: | Line 24: | ||
*[[Hypohidrosis]] | *[[Hypohidrosis]] | ||
*[[Rash]] | *[[Rash]] | ||
*[[Telangiectasias]] | *[[Telangiectasias]]<ref name="pmid21290701">{{cite journal| author=Mehta A, Beck M, Sunder-Plassmann G| title=Fabry Disease: Perspectives from 5 Years of FOS | journal= | year= 2006 | volume= | issue= | pages= | pmid=21290701 | doi= | pmc= | url= }}</ref> | ||
=== | |||
===Eyes=== | ===Eyes=== | ||
Line 36: | Line 31: | ||
*Corneal opacities | *Corneal opacities | ||
*[[Fundoscopy]]: | *[[Fundoscopy]]: | ||
**Retinal pathology may be found | **Retinal pathology may be found<ref name="pmid21290696">{{cite journal| author=Mehta A, Beck M, Sunder-Plassmann G| title=Fabry Disease: Perspectives from 5 Years of FOS | journal= | year= 2006 | volume= | issue= | pages= | pmid=21290696 | doi= | pmc= | url= }}</ref> | ||
===Ear=== | ===Ear=== | ||
*[[Sensorineural hearing loss]] may be present | *[[Sensorineural hearing loss]] may be present<ref name="pmid31072727">{{cite journal| author=Eyermann C, Raguin T, Rohmer D, Noel E, Charpiot A| title=Cochleovestibular manifestations in Fabry disease: Importance of screening and systematic ENT evaluation. | journal=Eur Ann Otorhinolaryngol Head Neck Dis | year= 2019 | volume= 136 | issue= 4 | pages= 273-279 | pmid=31072727 | doi=10.1016/j.anorl.2019.04.014 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31072727 }}</ref> | ||
===Heart=== | ===Heart=== | ||
Line 49: | Line 44: | ||
*Auscultation: | *Auscultation: | ||
**[[S3]] may be heard | **[[S3]] may be heard | ||
**[[Holosystolic murmur]] from [[mitral regurgitation]] | **[[Holosystolic murmur]] from [[mitral regurgitation]]<ref name="pmid21290675">{{cite journal| author=Mehta A, Beck M, Sunder-Plassmann G| title=Fabry Disease: Perspectives from 5 Years of FOS | journal= | year= 2006 | volume= | issue= | pages= | pmid=21290675 | doi= | pmc= | url= }}</ref> | ||
===Abdomen=== | ===Abdomen=== | ||
*[[Hepatomegaly]] | *[[Hepatomegaly]] | ||
*[[Splenomegaly]] | *[[Splenomegaly]]<ref name="pmid20955964">{{cite journal| author=vom Dahl S, Mengel E| title=Lysosomal storage diseases as differential diagnosis of hepatosplenomegaly. | journal=Best Pract Res Clin Gastroenterol | year= 2010 | volume= 24 | issue= 5 | pages= 619-28 | pmid=20955964 | doi=10.1016/j.bpg.2010.09.001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20955964 }}</ref> | ||
===Extremities=== | ===Extremities=== | ||
*[[Raynaud phenomenon]] | *[[Raynaud phenomenon]]<ref name="pmid25997047">{{cite journal| author=Deshayes S, Auboire L, Jaussaud R, Lidove O, Parienti JJ, Triclin N | display-authors=etal| title=Prevalence of Raynaud phenomenon and nailfold capillaroscopic abnormalities in Fabry disease: a cross-sectional study. | journal=Medicine (Baltimore) | year= 2015 | volume= 94 | issue= 20 | pages= e780 | pmid=25997047 | doi=10.1097/MD.0000000000000780 | pmc=4602884 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25997047 }}</ref> | ||
===Neurologic=== | ===Neurologic=== | ||
Line 69: | Line 64: | ||
*[[Seizure]]s | *[[Seizure]]s | ||
*[[Spasticity]] | *[[Spasticity]] | ||
*[[Peripheral neuropathy]] | *[[Peripheral neuropathy]]<ref name="pmid21290698">{{cite journal| author=Mehta A, Beck M, Sunder-Plassmann G| title=Fabry Disease: Perspectives from 5 Years of FOS | journal= | year= 2006 | volume= | issue= | pages= | pmid=21290698 | doi= | pmc= | url= }}</ref> | ||
===Other=== | ===Other=== | ||
*[[Fractures]] from [[Osteoporosis|osteoporotic bone]] | *[[Fractures]] from [[Osteoporosis|osteoporotic bone]]<ref name="pmid20001766">{{cite journal| author=Sacre K, Lidove O, Giroux Leprieur B, Ouali N, Laganier J, Caillaud C | display-authors=etal| title=Bone and joint involvement in Fabry disease. | journal=Scand J Rheumatol | year= 2010 | volume= 39 | issue= 2 | pages= 171-4 | pmid=20001766 | doi=10.3109/03009740903270631 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20001766 }}</ref> | ||
*[[Delayed puberty]]: lack of development of [[secondary sexual characteristics]] | *[[Delayed puberty]]: lack of development of [[secondary sexual characteristics]] | ||
*Male [[infertility]] | *Male [[infertility]] | ||
*[[Priapism]] | *[[Priapism]]<ref name="pmid29110178">{{cite journal| author=Meng XL, Arning E, Wight-Carter M, Day TS, Jabbarzadeh-Tabrizi S, Chen S | display-authors=etal| title=Priapism in a Fabry disease mouse model is associated with upregulated penile nNOS and eNOS expression. | journal=J Inherit Metab Dis | year= 2018 | volume= 41 | issue= 2 | pages= 231-238 | pmid=29110178 | doi=10.1007/s10545-017-0107-6 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29110178 }}</ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Up to Date]] |
Latest revision as of 18:50, 14 July 2022
Fabry's disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Fabry's disease physical examination On the Web |
American Roentgen Ray Society Images of Fabry's disease physical examination |
Risk calculators and risk factors for Fabry's disease physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ghazal Sanadgol, M.D.[2]
Overview
The presence of angiokeratomas on physical examination is highly suggestive of Fabry's disease. other physical examinations can be varied due to organ involvement.
Physical Examination
Appearance
- Severe growth retardation[1]
- Extreme mental and motor retardation[2]
Vital Signs
- Irregularly irregular pulse may be present from cardiac arrhythmias[3]
- Blood pressure may be raised[4]
- Pyrexia of unknown origin
Skin
Eyes
- Decreased visual acuity: Loss of vision or blurring of vision
- Corneal opacities
- Fundoscopy:
- Retinal pathology may be found[6]
Ear
- Sensorineural hearing loss may be present[7]
Heart
- Palpation:
- Auscultation:
- S3 may be heard
- Holosystolic murmur from mitral regurgitation[8]
Abdomen
Extremities
Neurologic
- Mental retardation
- Growth retardation
- Gradual loss of intellect
- Motor retardation
- Ataxia
- Seizures
- Spasticity
- Peripheral neuropathy[11]
Other
- Fractures from osteoporotic bone[12]
- Delayed puberty: lack of development of secondary sexual characteristics
- Male infertility
- Priapism[13]
References
- ↑ Laney DA, Peck DS, Atherton AM, Manwaring LP, Christensen KM, Shankar SP; et al. (2015). "Fabry disease in infancy and early childhood: a systematic literature review". Genet Med. 17 (5): 323–30. doi:10.1038/gim.2014.120. PMID 25232851.
- ↑ Sigmundsdottir L, Tchan MC, Knopman AA, Menzies GC, Batchelor J, Sillence DO (2014). "Cognitive and psychological functioning in Fabry disease". Arch Clin Neuropsychol. 29 (7): 642–50. doi:10.1093/arclin/acu047. PMC 4263929. PMID 25319043.
- ↑ Germain DP (2010). "Fabry disease". Orphanet J Rare Dis. 5: 30. doi:10.1186/1750-1172-5-30. PMC 3009617. PMID 21092187.
- ↑ Germain DP (2010). "Fabry disease". Orphanet J Rare Dis. 5: 30. doi:10.1186/1750-1172-5-30. PMC 3009617. PMID 21092187.
- ↑ Mehta A, Beck M, Sunder-Plassmann G (2006). "Fabry Disease: Perspectives from 5 Years of FOS". PMID 21290701.
- ↑ Mehta A, Beck M, Sunder-Plassmann G (2006). "Fabry Disease: Perspectives from 5 Years of FOS". PMID 21290696.
- ↑ Eyermann C, Raguin T, Rohmer D, Noel E, Charpiot A (2019). "Cochleovestibular manifestations in Fabry disease: Importance of screening and systematic ENT evaluation". Eur Ann Otorhinolaryngol Head Neck Dis. 136 (4): 273–279. doi:10.1016/j.anorl.2019.04.014. PMID 31072727.
- ↑ Mehta A, Beck M, Sunder-Plassmann G (2006). "Fabry Disease: Perspectives from 5 Years of FOS". PMID 21290675.
- ↑ vom Dahl S, Mengel E (2010). "Lysosomal storage diseases as differential diagnosis of hepatosplenomegaly". Best Pract Res Clin Gastroenterol. 24 (5): 619–28. doi:10.1016/j.bpg.2010.09.001. PMID 20955964.
- ↑ Deshayes S, Auboire L, Jaussaud R, Lidove O, Parienti JJ, Triclin N; et al. (2015). "Prevalence of Raynaud phenomenon and nailfold capillaroscopic abnormalities in Fabry disease: a cross-sectional study". Medicine (Baltimore). 94 (20): e780. doi:10.1097/MD.0000000000000780. PMC 4602884. PMID 25997047.
- ↑ Mehta A, Beck M, Sunder-Plassmann G (2006). "Fabry Disease: Perspectives from 5 Years of FOS". PMID 21290698.
- ↑ Sacre K, Lidove O, Giroux Leprieur B, Ouali N, Laganier J, Caillaud C; et al. (2010). "Bone and joint involvement in Fabry disease". Scand J Rheumatol. 39 (2): 171–4. doi:10.3109/03009740903270631. PMID 20001766.
- ↑ Meng XL, Arning E, Wight-Carter M, Day TS, Jabbarzadeh-Tabrizi S, Chen S; et al. (2018). "Priapism in a Fabry disease mouse model is associated with upregulated penile nNOS and eNOS expression". J Inherit Metab Dis. 41 (2): 231–238. doi:10.1007/s10545-017-0107-6. PMID 29110178.